Galmed Pharmaceuticals Ltd Long-term Investment Intensity
Galmed Pharmaceuticals Ltd long-term investment intensity. Galmed Pharmaceuticals Ltd (GLMD) has a Long-term Investment Intensity of 7.4% as of September 2025. Long-term investments of $1.59 Million represent 7.4% of total assets of $21.58 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Galmed Pharmaceuticals Ltd (GLMD) financial obligations for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Galmed Pharmaceuticals Ltd (2022–2024)
Long-term investment intensity of Galmed Pharmaceuticals Ltd from 2022 to 2024. This chart shows how Galmed Pharmaceuticals Ltd's Long-term Investment Intensity has evolved across 3 annual periods from 2022 to 2024. As of September 2025, the intensity stands at 7.4%, reflecting long-term investments of $1.59 Million against total assets of $21.58 Million USD.
Galmed Pharmaceuticals Ltd Long-term Investment Intensity by Year (2022–2024)
Galmed Pharmaceuticals Ltd long-term investment intensity by year from 2022 to 2024. The table below presents the year-by-year Long-term Investment Intensity for Galmed Pharmaceuticals Ltd from 2022 to 2024, covering 3 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Galmed Pharmaceuticals Ltd.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 11.5% | $2.12 Million | $18.50 Million | ▼ -8.2 pp |
| 2023 | 19.6% | $3.27 Million | $16.63 Million | ▲ +10.6 pp |
| 2022 | 9.1% | $1.50 Million | $16.56 Million | — |